The prevalence of hepatitis B e antigen (HBeAg) was higher in patients with HBV/CD1 (63.3%) than that in patients with HBV/C2 (50.0%), but the difference did not reach statistical significance ( P = 0.118).
← all excerpts
Geographical and ethnic distribution of the HBV C/D recombinant on the Qinghai-Tibet Plateau.
1
0.1180
0.1180